Filter announcements
Loading...
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
Consolidated financials for Remus Pharmaceuticals reveal a robust performance for the half-year ended September 30, 2024. Total revenue surged to ₹4,218.52 crore, reflecting a significant year-over-year growth. This increase can be attributed to heightened demand for pharmaceutical products and successful market expansion efforts. Net profit for the period stood at...